Chemical Bull Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -99.82%
(FY 2023)
- Profit 93.48%
(FY 2023)
- Ebitda 94.30%
(FY 2023)
- Net Worth -72.96%
(FY 2023)
- Total Assets -44.04%
(FY 2023)
About Chemical Bull
The Corporate was formerly known as Three Eyes Deals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kamleshkumar Singh and Namish Singh serve as directors at the Company.
- CIN/LLPIN
U51909GJ2016PTC093413
- Company No.
093413
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vapi, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Chemical Bull Private Limited offer?
Chemical Bull Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Cardiovascular Drugs & Medication, Antianginal Drugs, Pharma Ingredients & Raw Materials, API Intermediate, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nervous System and Antipsychotic API, Cardiac Drugs.
Who are the key members and board of directors at Chemical Bull?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamleshkumar Singh  | Director | 18-Aug-2016 | Current |
| Namish Singh | Director | 17-Sep-2020 | Current |
Financial Performance of Chemical Bull.
Chemical Bull Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.82% decrease. The company also saw a substantial improvement in profitability, with a 93.48% increase in profit. The company's net worth observed a substantial decline by a decrease of 72.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemical Bull?
In 2023, Chemical Bull had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Triveni Interchem Private LimitedActive 14 years 8 monthsKamleshkumar Singh and Namish Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemical Bull?
Chemical Bull has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemical Bull, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemical Bull's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
